Apiam Animal Health Limited (ASX:AHX)
Australia
· Delayed Price · Currency is AUD 0.4050
-0.0050 (-1.22%)
Apr 24, 2025, 3:40 PM AEST
Apiam Animal Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Revenue | 206.45 | 204.66 | 191.76 | 157.06 | 126.18 | 118.34 | Upgrade
|
| Revenue Growth (YoY) | 2.00% | 6.73% | 22.09% | 24.47% | 6.63% | 5.92% | Upgrade
|
| Cost of Revenue | 159.14 | 157.49 | 152.41 | 122.72 | 100.87 | 94.52 | Upgrade
|
| Gross Profit | 47.31 | 47.17 | 39.35 | 34.34 | 25.32 | 23.82 | Upgrade
|
| Selling, General & Admin | - | - | - | - | 2.14 | 2.12 | Upgrade
|
| Other Operating Expenses | 22.1 | 22.16 | 22.24 | 18.2 | 8.54 | 7.98 | Upgrade
|
| Operating Expenses | 34.65 | 34.14 | 32.47 | 26.55 | 17.1 | 16.16 | Upgrade
|
| Operating Income | 12.66 | 13.03 | 6.88 | 7.78 | 8.21 | 7.66 | Upgrade
|
| Interest Expense | -5.77 | -5.52 | -3.77 | -1.57 | -1.18 | -1.37 | Upgrade
|
| Earnings From Equity Investments | 0.03 | 0.05 | 0.05 | 0.09 | 0.08 | 0.05 | Upgrade
|
| EBT Excluding Unusual Items | 6.92 | 7.55 | 3.16 | 6.3 | 7.12 | 6.33 | Upgrade
|
| Merger & Restructuring Charges | -0.67 | -0.67 | -0.32 | - | -0.17 | -0.46 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.17 | 0.17 | 0.32 | 0.17 | 0.02 | 0.08 | Upgrade
|
| Pretax Income | 1.92 | 7.06 | 3.17 | 6.47 | 6.97 | 5.96 | Upgrade
|
| Income Tax Expense | 1.77 | 2.15 | 1 | 1.93 | 2.02 | 1.74 | Upgrade
|
| Earnings From Continuing Operations | 0.16 | 4.91 | 2.17 | 4.54 | 4.95 | 4.22 | Upgrade
|
| Minority Interest in Earnings | -0.03 | 0.02 | 0.11 | 0.1 | 0.09 | -0.12 | Upgrade
|
| Net Income | 0.13 | 4.93 | 2.28 | 4.64 | 5.04 | 4.09 | Upgrade
|
| Net Income to Common | 0.13 | 4.93 | 2.28 | 4.64 | 5.04 | 4.09 | Upgrade
|
| Net Income Growth | -95.23% | 116.56% | -50.92% | -7.88% | 22.98% | 29.38% | Upgrade
|
| Shares Outstanding (Basic) | 180 | 179 | 175 | 136 | 121 | 113 | Upgrade
|
| Shares Outstanding (Diluted) | 182 | 182 | 178 | 138 | 122 | 114 | Upgrade
|
| Shares Change (YoY) | 0.75% | 2.38% | 28.68% | 13.16% | 6.75% | 8.27% | Upgrade
|
| EPS (Basic) | 0.00 | 0.03 | 0.01 | 0.03 | 0.04 | 0.04 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.03 | 0.01 | 0.03 | 0.04 | 0.04 | Upgrade
|
| EPS Growth | -95.49% | 111.73% | -61.91% | -18.64% | 15.36% | 19.34% | Upgrade
|
| Free Cash Flow | 13.32 | 14.1 | 9.55 | 10.72 | 8.95 | 5.86 | Upgrade
|
| Free Cash Flow Per Share | 0.07 | 0.08 | 0.05 | 0.08 | 0.07 | 0.05 | Upgrade
|
| Dividend Per Share | 0.020 | 0.020 | - | 0.016 | 0.024 | 0.020 | Upgrade
|
| Dividend Growth | 100.00% | - | - | -33.33% | 20.00% | 25.00% | Upgrade
|
| Gross Margin | 22.91% | 23.05% | 20.52% | 21.86% | 20.06% | 20.13% | Upgrade
|
| Operating Margin | 6.13% | 6.37% | 3.59% | 4.96% | 6.51% | 6.47% | Upgrade
|
| Profit Margin | 0.06% | 2.41% | 1.19% | 2.95% | 3.99% | 3.46% | Upgrade
|
| Free Cash Flow Margin | 6.45% | 6.89% | 4.98% | 6.82% | 7.09% | 4.95% | Upgrade
|
| EBITDA | 16.95 | 19.6 | 12.98 | 12.82 | 12.11 | 11.3 | Upgrade
|
| EBITDA Margin | 8.21% | 9.58% | 6.77% | 8.16% | 9.60% | 9.55% | Upgrade
|
| D&A For EBITDA | 4.29 | 6.58 | 6.1 | 5.04 | 3.9 | 3.64 | Upgrade
|
| EBIT | 12.66 | 13.03 | 6.88 | 7.78 | 8.21 | 7.66 | Upgrade
|
| EBIT Margin | 6.13% | 6.37% | 3.59% | 4.96% | 6.51% | 6.47% | Upgrade
|
| Effective Tax Rate | 91.83% | 30.50% | 31.43% | 29.84% | 28.99% | 29.23% | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.